
TelyRx is spreading out in a big way in Clearwater, tripling its headquarters from roughly 6,300 square feet to nearly 19,500 after the cash‑pay digital pharmacy said it has now filled more than one million prescriptions. The company is pairing that real estate grab with a 180% year‑over‑year jump in first‑quarter revenue, a surge executives say backs the need for more fulfillment muscle and clinical space. The larger footprint is designed to speed up order turnaround, expand pharmacy operations and make room for new local hires.
The expansion and growth figures were laid out in a July 14 press release, as reported by PR Newswire. "Filling one million prescriptions is a milestone worth celebrating," TelyRx CEO Vanessa Slowey said in the statement. The release added that repeat customers are fueling much of the momentum and that the extra capacity is meant to keep deliveries quick as more patients opt for direct‑to‑consumer care.
Tripling the Clearwater footprint
The Tampa Bay Business Journal detailed how the headquarters footprint grew from about 6,300 square feet to nearly 19,500, tying that jump directly to the company’s recent revenue gains. As reported by Tampa Bay Business Journal, executives pointed to a rising volume of repeat orders and the push for faster fulfillment as key reasons for beefing up the local operation.
Numbers behind the surge
TelyRx has also filed audited financials that show revenue climbed to $42.9 million for the year ended Dec. 31, 2025, up from $9.5 million in the prior period. The figures were posted on the company’s investor site and to SEDAR+. As outlined on TelyRx, the firm says it has increased revenue quarter after quarter as it scales its model.
Local hiring and licensing
The company says the Clearwater buildout will be matched with hiring across pharmacy, clinical and fulfillment roles in order to keep service levels and order accuracy in line with the growing demand, according to the press release. Licensing records from the Florida Department of Health list a TelyRx‑licensed community pharmacy in Clearwater, confirming the company’s on‑the‑ground presence and regulatory standing. Company materials state that the larger footprint is intended to preserve turnaround times and accuracy as more customers sign on.
What it means for patients and the market
Prescription spending has been rising across the country, and analysts note that mail and digital dispensing now claim a growing slice of that pie. That helps explain why cash‑pay, direct‑to‑consumer models are scaling quickly rather than fading as a fad. A forecast in the American Journal of Health‑System Pharmacy points to continued upward pressure on prescription expenditures, a trend companies like TelyRx are positioning themselves to serve.
For Clearwater, the expansion puts a fast‑growing digital pharmacy more squarely on the local map and promises additional jobs at a time when fulfillment and healthcare logistics are becoming increasingly local stories. TelyRx says the added space is intended to protect the service levels that executives credit with driving its repeat business.









